These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1284315)

  • 1. [The role of neurotransmitters in psychiatric pathology].
    Gherardi D; Fabrizio E; Chirillo S; Garzia P
    Minerva Psichiatr; 1992; 33(4):247-58. PubMed ID: 1284315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Modifications of cerebral amine metabolism in psychiatric illness].
    Linkowski P; Mendlewicz J
    Acta Psychiatr Belg; 1980; 80(5):559-73. PubMed ID: 6165224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 5-hydroxytryptophan on brain levels of dopamine, norepinephrine, and serotonin in mice.
    Everett GM
    Adv Biochem Psychopharmacol; 1974; 10():261-2. PubMed ID: 4546516
    [No Abstract]   [Full Text] [Related]  

  • 4. [The probenecid test. Evaluation in clinical medicine of cerebral metabolism of serotonin and dopamine].
    Véron JP; Mérienne L
    Nouv Presse Med; 1972 Feb; 1(8):537-9. PubMed ID: 4258943
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure-function relations in schizophrenia: brain morphology and neuropsychology.
    Bilder RM
    Prog Exp Pers Psychopathol Res; 1992; 15():183-251. PubMed ID: 1285281
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of intraventricular injection of 6-hydroxydopamine on sleep states and cerebral monoamines in cats].
    Laguzzi R; Petitjean F; Pujol JE; Jouvet M
    C R Seances Soc Biol Fil; 1971; 165(7):1649-53. PubMed ID: 4340383
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of pethidine on central neurotransmitters: changes in the state of tolerance.
    Nowakowska E; Chodera A; Szczawińska K; Cenajek D
    Pol J Pharmacol Pharm; 1986; 38(2):143-8. PubMed ID: 2428018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-chloroamphetamine: in vivo investigations on the mechanism of action of the selective depletion of cerebral serotonin.
    Sanders-Bush E; Sulser F
    J Pharmacol Exp Ther; 1970 Nov; 175(2):419-26. PubMed ID: 5312363
    [No Abstract]   [Full Text] [Related]  

  • 9. Biogenic amines metabolism and blood chemistry of psychiatric patients.
    Ebuehi OA; Bishop SA; Fanmuyiwa OO; Akinwande AI; Ladenegan OA
    Afr J Med Med Sci; 2001 Dec; 30(4):269-73. PubMed ID: 14510102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded ontogeny of neurotransmitters and their metabolites in the brains of fetal and newborn lambs.
    Richards GE; Gluckman PD; Ball K; Mannelli SC; Kalamaras JA
    J Dev Physiol; 1990 Dec; 14(6):331-6. PubMed ID: 1713933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Old and new thought concepts on the biochemical principles of psychopharmcotherapy].
    Wunderlich H; Wunderlich HP
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():61-80. PubMed ID: 6130615
    [No Abstract]   [Full Text] [Related]  

  • 12. [Suicidal behavior: clinical considerations].
    De Leo D; Pavan L
    Minerva Psichiatr; 1992; 33(4):289-95. PubMed ID: 1284316
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain monoamine changes in chronic paranoid schizophrenia and their possible relation to increased dopamine receptor sensitivity.
    Farley IJ; Shannak KS; Hornykiewicz O
    Adv Biochem Psychopharmacol; 1980; 21():427-33. PubMed ID: 6155058
    [No Abstract]   [Full Text] [Related]  

  • 14. Response of neurogenic amines to aggregation and strangers.
    Bliss EL; Ailion J
    J Pharmacol Exp Ther; 1969 Aug; 168(2):258-63. PubMed ID: 5816819
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia.
    Oades RD; Klimke A; Henning U; Rao ML
    Hum Psychopharmacol; 2002 Jan; 17(1):15-27. PubMed ID: 12404703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion.
    Kmieciak-Kołada K; Felińska W; Stachura Z; Majchrzak H; Herman ZS
    Pol J Pharmacol Pharm; 1987; 39(1):47-53. PubMed ID: 2444951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of HIAA and VMA in c.s.f. of schizophrenics before and after treatment.
    Okasha A; Eid SZ; Bishry Z; Lotaif F; Gouda JF
    Egypt J Psychiatry; 1978 Dec; 1(1):38-50. PubMed ID: 95598
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress.
    Bliss EL; Ailion J; Zwanziger J
    J Pharmacol Exp Ther; 1968 Nov; 164(1):122-34. PubMed ID: 4387046
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of chronic imipramine administration on rat brain levels of serotonin, 5-hydroxyindoleacetic acid, norepinephrine and dopamine.
    Alpers HS; Himwich HE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):531-8. PubMed ID: 5012780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.